Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX® platform across India. Under the agreement, ILS will distribute [...]

On its 20th anniversary, DECTRIS extends its mission further, from detecting the invisible to transforming it into the understandable with a platform designed to connect data, analyses, compute, and scientific context into one home for modern research. Science has changed Over the past two decades, science has become fundamentally more complex and computational. Experiments generate [...]

New Juno Bio lab infrastructure marks a major step in scaling provider-led care and advancing precision vaginal microbiome testing OAKLAND, Calif. -- Juno Bio, a women's health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women's [...]

Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan’s Evercode WT services SEATTLE — Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider [...]

Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio. As leaders in AI-driven drug discovery, design, and development, alliance members will use the unprecedented [...]

BREMEN, Germany -- Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH. The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples DISQVER® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker's NGS-based [...]

FREMONT, Calif. -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The new site has been renovated [...]

$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO -- Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month Direct-to-Phase II Small Business Innovation Research award from the National Center for Advancing Translational Sciences (NCATS), part of the [...]

The operation brings photohyperpolarization technology to the Spinsolve platform and benchtop NMR biophysics. "This is what real innovation in benchtop NMR looks like, and it is happening here.” — Federico Casanova AACHEN, NORTH RHINE-WESTPHALIA, GERMANY -- Magritek, the global leader in benchtop nuclear magnetic resonance (NMR) instrumentation, today announced that NexMR, developer of advanced photohyperpolarization technology, [...]

this appointment reflects the company's continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience SAN DIEGO -- Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring strategic depth to Rancho's product direction and growth [...]